Your genes may hold the key to which diabetes drug works best
Knowledge-focused
Completed
This study aimed to understand why some people respond better than others to certain diabetes medications. Researchers followed 260 obese adults with newly diagnosed Type 2 diabetes for six months, giving them either empagliflozin, dapagliflozin, or standard care. The main goal w…
Phase: PHASE4 • Sponsor: Erbil Polytechnic University • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:41 UTC